Proposed Collection; Comment Request; Women's Health Initiative Observational Study, 67494-67495 [05-22078]
Download as PDF
<![CDATA[
67494
Federal Register / Vol. 70, No. 214 / Monday, November 7, 2005 / Notices
mail address, and fax number) at least
5 workdays before the public meeting
date. We encourage you to register
online at https://www.cfsan.fda.gov/comm/register.html. or to fax your
registration directly to Marion V. Allen
at 301–436–2605. We will accept
registrations onsite. Space is limited and
registration will be closed when
maximum seating capacity is reached
(250 people). If you need special
accommodations due to a disability,
please notify Marion V. Allen at least 7
workdays in advance.
We encourage individuals or firms
with relevant data or information to
present such information at the meeting
or in written comments to the record. If
you would like to make oral comments
at the meeting, please specify your
interest in speaking when you register.
The amount of time for each oral
presentation will be limited to 5
minutes.
IV. Transcripts
A transcript will be made of the
proceedings of the meeting. You may
request a copy of the meeting transcript
in writing approximately 30 working
days after the public meeting at a cost
of 10 cents per page from:
FDA: FDA’s Freedom of Information
Office (HFI–35), Food and Drug
Administration, 5600 Fishers Lane, rm.
12A–16, Rockville, MD 20857; or
FSIS: FSIS, Freedom of Information
Office, USDA, 1400 Independence Ave.,
SW., Room 1140 South Building,
Washington, DC 20250.
The transcript of the public meeting
and all comments submitted will be
available for public examination at the
Agencies’ Docket Offices (see
ADDRESSES for locations and hours).
V. Comments
In addition to presenting oral
comments at the public meeting,
interested persons may submit written
or electronic comments on the subject of
this meeting and Federal Register notice
to a joint agency docket housed at FSIS.
FSIS: Submit comments by any of the
following methods: Mail, including
floppy disks or CD–ROMs, and hand- or
courier-delivered items.
Comments are to be identified by the
Docket No. 05–013N. All comments
submitted in response to this notice will
be available for public inspection in the
Agencies’ Docket offices and web sites.
[See ADDRESSES section for location and
hours].
Additional Public Notification
Public awareness of all segments of
rulemaking and policy development is
important. Consequently, in an effort to
ensure that the public and in particular
minorities, women, and persons with
disabilities, are aware of this notice,
FSIS will announce it on-line through
the FSIS Web page located at https://
www.fsis.usda.gov/regulations/
2005_Notices_Index/index.asp.
FSIS also will make copies of this
Federal Register publication available
through the FSIS Constituent Update,
which is used to provide information
regarding FSIS policies, procedures,
regulations, Federal Register notices,
FSIS public meetings, recalls, and other
types of information that could affect or
would be of interest to our constituents
and stakeholders. The update is
communicated via Listserv, a free e-mail
subscription service consisting of
industry, trade, and farm groups,
consumer interest groups, allied health
professionals, scientific professionals,
and other individuals who have
requested to be included. The update
also is available on the FSIS web page.
Through Listserv and the web page,
FSIS is able to provide information to a
much broader, more diverse audience.
In addition, FSIS offers an e-mail
subscription service which provides an
automatic and customized notification
when popular pages are updated,
including Federal Register publications
and related documents. This service is
available at https://www.fsis.usda.gov/
news_and_events/email_subscription/
and allows FSIS customers to sign up
for subscription options across eight
categories. Options range from recalls to
export information to regulations,
directives and notices.
Customers can add or delete
subscriptions themselves and have the
option to password protect their
account.
Done in Washington DC on: November 2,
2005.
Jeffrey E. Shuren,
Assistant Commissioner for Policy, Food and
Drug Administration.
Sean Altekruse,
Deputy Executive Associate Administrator,
OPPED, Food Safety Inspection Service.
[FR Doc. 05–22123 Filed 11–3–05; 8:45 am]
Estimated
number of
respondents
OS Participants ............................................................................................
16:38 Nov 04, 2005
Jkt 208001
National Institutes of Health
Proposed Collection; Comment
Request; Women’s Health Initiative
Observational Study
Summary: In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, Office
of the Director, the National Heart,
Lung, and Blood Institute (NHLBI), the
National Institutes of Health (NIH) will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Proposed Collection: Title: Women’s
Health Initiative (WHI) Observational
Study. Type of Information Collection
Request: Revision OMB #0925–0414
Exp: 04/06. Need for Use of Information
Collection: This study will be used by
the NIH to evaluate risk factors for
chronic disease among older women by
developing and following a large cohort
of postmenopausal women and relating
subsequent disease development to
baseline assessments of historical,
physical, psychosocial, and physiologic
characteristics. In addition, the
observational study will complement
the clinical trial (which has received
clinical exemption) and provide
additional information on the common
causes of frailty, disability and death for
postmenopausal women, namely,
coronary heart disease, breast and
colorectal cancer, and osteoporotic
fractures. Continuation of follow-up
years for ascertainment of medical
history update forms will provide
essential data for outcomes assessment
for this population of aging women.
Frequency of Response: On occasion.
Affected Public: Individuals and
physicians. Type of Respondents:
Women, next-of-kin, and physician’s
office staff. The annual reporting burden
is as follows:
BILLING CODE 3410–DM–P
Type of respondents
VerDate Aug<31>2005
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Frm 00085
Fmt 4703
Estimated
number of responses per
respondent
85,786
Sfmt 4703
E:\FR\FM\07NON1.SGM
Average burden
hours per
response
1
07NON1
.21
Estimated total
annual burden
hours requested
18,195
67495
Federal Register / Vol. 70, No. 214 / Monday, November 7, 2005 / Notices
Estimated
number of
respondents
Type of respondents
Estimated
number of responses per
respondent
Average burden
hours per
response
Estimated total
annual burden
hours requested
124
.33
Next-of-kin ....................................................................................................
Physician’s Office Staff ................................................................................
1,483
4
1
1
.0835
.0835
Total ......................................................................................................
87,273
........................
..........................
The annualized cost burden to
respondents is $290,230. There are no
annual Capital Costs, Operating Costs
and/or Maintenance Costs to report.
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies should
address one or more of the following
points: (1) Evaluate whether the
proposed collection is necessary for the
proper performance of the function of
the agency, including whether the
information will have practical utility;
(2) evaluate the accuracy of the agency’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) enhance the
quality, utility, and clarity of the
information to be collected; and (4)
minimize the burden of the collection of
information on those who are to
respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
For Further Information Contact: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Dr. Linda Pottern,
Project Officer, Women’s Health
Initiative Program Office, National
Institutes of Health, 6701 Rockledge
Drive, 2 Rockledge Centre, Suite 8204,
MSC 7935, Bethesda, MD 20892–7935,
or call 301–402–2900 or E-mail your
request, including your address to:
potternl@mail.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60-days of the date of
this publication.
Dated: October 28, 2005.
Jacques Rossouw,
NHLBI, WHI Project Officer, National
Institutes of Health.
[FR Doc. 05–22078 Filed 11–4–05; 8:45 am]
BILLING CODE 4140–01–P
VerDate Aug<31>2005
16:38 Nov 04, 2005
Jkt 208001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel, SEP (ZHG1 HGR N J1).
Date: November 10, 2005.
Time: 1:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Ken D. Nakamura, PhD,
Scientific Review Administrator, Scientific
Review Branch, National Human Genome
Research Institute, National Institutes of
Health, 5635 Fishers Lane, Suite 4076, MSC
9306, Rockville, MD 20852, 301–402–0838.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel, Design and Analysis RFA.
Date: December 5–6, 2005.
Time: 8:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Rudy O. Pozzatti, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Human Genome
Research Institute, National Institutes of
Health, Bethesda, MD 20892, 301 402–0838.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
18,319
Dated: October 26, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–22076 Filed 11–04–05; 8:45am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Program
Project.
Date: December 1, 2005.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Mark Swieter, PhD, Chief,
Training and Special Projects Review Branch,
Office of Extramural Affiars, National
Institute on Drug Abuse, NIH, DHHS, 6101
Executive Boulevard, Suite 220, Bethesda,
MD 20892–8401, (301) 435–1389,
ms80x@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878; 93.892, 93.893, National
Institutes of Health, HHS)
E:\FR\FM\07NON1.SGM
07NON1
]]>Agencies
[Federal Register Volume 70, Number 214 (Monday, November 7, 2005)]
[Notices]
[Pages 67494-67495]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-22078]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment Request; Women's Health Initiative
Observational Study
Summary: In compliance with the requirement of Section
3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity
for public comment on proposed data collection projects, Office of the
Director, the National Heart, Lung, and Blood Institute (NHLBI), the
National Institutes of Health (NIH) will publish periodic summaries of
proposed projects to be submitted to the Office of Management and
Budget (OMB) for review and approval.
Proposed Collection: Title: Women's Health Initiative (WHI)
Observational Study. Type of Information Collection Request: Revision
OMB 0925-0414 Exp: 04/06. Need for Use of Information
Collection: This study will be used by the NIH to evaluate risk factors
for chronic disease among older women by developing and following a
large cohort of postmenopausal women and relating subsequent disease
development to baseline assessments of historical, physical,
psychosocial, and physiologic characteristics. In addition, the
observational study will complement the clinical trial (which has
received clinical exemption) and provide additional information on the
common causes of frailty, disability and death for postmenopausal
women, namely, coronary heart disease, breast and colorectal cancer,
and osteoporotic fractures. Continuation of follow-up years for
ascertainment of medical history update forms will provide essential
data for outcomes assessment for this population of aging women.
Frequency of Response: On occasion. Affected Public: Individuals and
physicians. Type of Respondents: Women, next-of-kin, and physician's
office staff. The annual reporting burden is as follows:
----------------------------------------------------------------------------------------------------------------
Estimated Estimated
Estimated number of Average burden total annual
Type of respondents number of responses per hours per burden hours
respondents respondent response requested
----------------------------------------------------------------------------------------------------------------
OS Participants................................. 85,786 1 .21 18,195
[[Page 67495]]
Next-of-kin..................................... 1,483 1 .0835 124
Physician's Office Staff........................ 4 1 .0835 .33
-----------------
Total....................................... 87,273 .............. .............. 18,319
----------------------------------------------------------------------------------------------------------------
The annualized cost burden to respondents is $290,230. There are no
annual Capital Costs, Operating Costs and/or Maintenance Costs to
report.
Request for Comments: Written comments and/or suggestions from the
public and affected agencies should address one or more of the
following points: (1) Evaluate whether the proposed collection is
necessary for the proper performance of the function of the agency,
including whether the information will have practical utility; (2)
evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) enhance the quality, utility, and
clarity of the information to be collected; and (4) minimize the burden
of the collection of information on those who are to respond, including
the use of appropriate automated, electronic, mechanical, or other
technological collection techniques or other forms of information
technology.
For Further Information Contact: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Dr. Linda Pottern, Project Officer, Women's
Health Initiative Program Office, National Institutes of Health, 6701
Rockledge Drive, 2 Rockledge Centre, Suite 8204, MSC 7935, Bethesda, MD
20892-7935, or call 301-402-2900 or E-mail your request, including your
address to: potternl@mail.nih.gov.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60-days
of the date of this publication.
Dated: October 28, 2005.
Jacques Rossouw,
NHLBI, WHI Project Officer, National Institutes of Health.
[FR Doc. 05-22078 Filed 11-4-05; 8:45 am]
BILLING CODE 4140-01-P
